Patel, Avignat S.
Miller, Ezra
Regis, Shawn M.
Hunninghake, Gary M.
Price, Lori Lyn
Gawlik, Melissa
McKee, Andrea B.
Rieger-Christ, Kimberly M.
Pinto-Plata, Victor
Liesching, Timothy N.
Wald, Christoph
Hashim, Jeffrey
McKee, Brady J.
Gazourian, Lee
Clinical trials referenced in this document:
Documents that mention this clinical trial
Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis
https://doi.org/10.1186/s12931-023-02359-9
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR002544)
Genentech (ML42663)
National Institutes of Health (R01 HL111024, R01 HL135142, R01 HL1130974)
Article History
Received: 20 July 2022
Accepted: 6 February 2023
First Online: 14 February 2023
Declarations
:
: The study was approved by the Lahey Clinic, Inc, Institutional Review Board, Protocol #20203157. The need for individual consent was waived by the IRB.
: Not applicable.
: A.S.P., E.M., J.H., B.J.M, and L.G. were supported by a grant from Genentech, Inc. G.M.H reports consulting fees from Boehringer-Ingelheim and Gerson Lehrman Group outside the submitted work. A.B.M. reports consulting fees from Astra Zeneca outside the submitted work. B.J.M. reports consulting fees from Astra Zeneca and royalties from UpToDate® outside the submitted work. L.L.P, M.G., K.R–C., T.N.L, V.P-P., C.W. report none.